Mereo BioPharma Group plc (MREO)

NASDAQ: MREO · Real-Time Price · USD

0.4400

0.00 (0.00%)

At close: Jan 30, 2026, 4:00 PM EST

0.4563

+0.0163 (3.70%)

After-hours: Jan 30, 2026, 7:47 PM EST

Mereo BioPharma Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	70	542	323	88	174	242
Market Cap Growth	-85.08%	67.64%	269.38%	-49.64%	-28.05%	276.02%
Enterprise Value	22	468	282	17	50	221
Last Close Price	0.44	3.50	2.31	0.75	1.60	3.58
PE Ratio	-	-	-	-	10.09	-
PS Ratio	139.20	-	32.34	-	3.52	-
PB Ratio	1.50	8.89	6.40	1.70	1.46	-11.82
P/TBV Ratio	1.52	8.99	6.54	1.70	2.02	-
EV/Sales Ratio	43.43	-	28.17	-	1.02	-
Debt / Equity Ratio	0.01	0.11	0.12	0.30	0.19	-1.20
Asset Turnover	0.01	-	0.14	-	0.39	-
Quick Ratio	8.35	5.24	6.38	2.89	7.66	3.23
Current Ratio	8.71	5.40	6.72	3.09	7.92	3.47
Return on Equity (ROE)	-69.79%	-77.58%	-57.81%	-53.63%	34.85%	-1294.27%
Return on Assets (ROA)	-39.81%	-39.99%	-23.57%	-28.67%	-13.82%	-31.43%
Return on Invested Capital (ROIC)	-	-	-	-825.95%	-	-220.12%
Return on Capital Employed (ROCE)	-95.30%	-73.10%	-47.60%	-99.40%	-18.40%	-69.10%
Earnings Yield	-59.37%	-7.98%	-9.11%	-48.22%	9.91%	-92.45%
FCF Yield	-46.74%	-6.06%	-6.54%	-55.78%	-4.50%	-16.02%
Buyback Yield / Dilution	-9.71%	-12.16%	-9.33%	-8.63%	-63.82%	-279.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q